Anthrax protective antigen IgG ELISA Kit (DEIA3151)

Regulatory status: For research use only, not for use in diagnostic procedures.

Write a review

Size
96T
Sample
serum
Species Reactivity
Human
Intended Use
The Anthrax protective antigen (PA) IgG ELISA Kit is intended for use in the evaluation of patient's immune status or exposure to Anthrax.
Contents of Kit
1. Microwells
2. Sample Diluent
4. Positive Control
5. Negative Control
6. Enzyme conjugate
7. TMB Substrate
9. Wash concentrate
Storage
Store the complete kit at 2-8°C. For more detailed information, please download the following document on our website.

Citations


Have you cited DEIA3151 in a publication? Let us know and earn a reward for your research.

Customer Reviews


Write a review, share your experiences with others and get rewarded !
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket

References


Zeng, MT; Xu, QF; et al. Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine. VACCINE 25:3588-3594(2007).
Chabot, DJ; Scorpio, A; et al. Anthrax capsule vaccine protects against experimental infection. VACCINE 23:43-47(2004).

Online Inquiry

Name:
Phone: *
E-mail Address: *
Technology Interest:
Type of Organization:
Service & Products Interested: *
Project Description:

Related Products

Related Resources

Ordering Information

Payment methods we support:
Invoice / Purchase Order
Credit card

Inquiry Basket